Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019209 (
hepatomegaly
)
5,798
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors, and it is assumed that the biological effects of these receptors depend on interactions with recently identified coactivators, including
steroid receptor coactivator-1
(
SRC-1
). We assessed the in vivo function of
SRC-1
on the PPARalpha-regulated gene expression in liver by generating mice in which the
SRC-1
gene was inactivated by gene targeting. The homozygous (
SRC-1
(-/-)) mice were viable and fertile and exhibited no detectable gross phenotypic defects. When challenged with a PPARalpha ligand, such as ciprofibrate or Wy-14,643, the
SRC-1
(-/-) mice displayed typical pleiotropic responses, including
hepatomegaly
, peroxisome proliferation in hepatocytes, and increased mRNA and protein levels of genes that are regulated by PPARalpha. These alterations were indistinguishable from those exhibited by
SRC-1
(+/+) wild-type mice fed either ciprofibrate- or Wy-14, 643-containing diets. These results indicate that
SRC-1
is not essential for PPARalpha-mediated transcriptional activation in vivo and suggest redundancy in nuclear receptor coactivators.
...
PMID:Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression. 999 68